Product Information |
Synonym(s) |
EED226, EED 226 |
Chemical Name |
N-(Furan-2-ylmethyl)-8-(4-(methylsulfonyl)phenyl)[1,2,4]-triazolo[4,3-c]pyrimidin-5-amine |
Application |
EED-226 is a potent, selective, and orally bioavailable embryonic ectoderm development (EED) inhibitor |
CAS Number |
2083627-02-3 |
Purity |
≥99.5% |
Molecular Weight |
369.4 |
Molecular Formula |
C₁₇H₁₅N₅O₃S |
SMILES |
CS(=O)(=O)C1=CC=C(C=C1)C2=CN=C(N3C2=NN=C3)NCC4=CC=CO4 |
Target & IC50 |
EED;=82nM(Kd) PRC2;=114nM(Kd) |
Solubility |
DMSO: 73 mg/mL (197.62 mM) |
Preparing Stock Solutions |
ConcentrationSolventMass |
1 mg |
5 mg |
10 mg |
1 mM |
2.7071 ml |
13.5354 ml |
27.0709 ml |
5 mM |
0.5414 ml |
2.7071 ml |
5.4142 ml |
10 mM |
0.2707 ml |
1.3535 ml |
2.7071 ml |
50 mM |
0.0541 ml |
0.2707 ml |
0.5414 ml |
|
Shipping |
Gel Pack |
Storage |
Store at -20°C |
Research Use |
For Research Use Only. Not Intended for Diagnostic Or Therapeutic Use. |